10 Stocks That Will Profit From AI

8. Tempus AI, Inc. (NASDAQ:TEM)

EPS next year: 133.41%

Number of Hedge Fund Holders: 17

Tempus AI, Inc. (NASDAQ:TEM) is a healthcare technology company that leverages artificial intelligence to advance precision medicine and patient care. Its offerings include next-generation sequencing diagnostics and polymerase chain reaction testing, serving healthcare providers, pharmaceutical companies, and researchers. ​

In Q4 2024, Tempus AI, Inc. (NASDAQ:TEM) reported a 35.8% year-over-year revenue increase to $200.7 million, with genomics revenue growing by 30.6% and data and services revenue by 44.6%. Gross profit rose by 49.7% to $122.1 million, and the company reduced its net loss to $13.0 million from $50.5 million in the same quarter the previous year. Adjusted EBITDA improved to a loss of $7.8 million compared to a loss of $35.1 million in Q4 2023.

In February 2025, Tempus AI, Inc. (NASDAQ:TEM) completed the acquisition of Ambry Genetics, enhancing its capabilities in genetic testing and data services.

Tempus’s stock has experienced significant volatility in 2025. After soaring 108% earlier in the year, shares declined by 15.1% to $59.10 following concerns about long-term growth prospects. Despite this, the stock remains approximately 45% above its initial public offering price since June, which makes it one of the best AI stocks to invest in.

Analyst consensus rates Tempus AI, Inc. (NASDAQ:TEM) as “Overweight,” with an average target price of $63.70 as of 25 March. The company’s full-year 2025 revenue guidance stands at $1.24 billion, including contributions from Ambry Genetics.